Literature DB >> 18413573

PARK9-linked parkinsonism in eastern Asia: mutation detection in ATP13A2 and clinical phenotype.

Y P Ning1, K Kanai, H Tomiyama, Y Li, M Funayama, H Yoshino, S Sato, M Asahina, S Kuwabara, A Takeda, T Hattori, Y Mizuno, N Hattori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18413573     DOI： 10.1212/01.wnl.0000310427.72236.68

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  30 in total

Review 1.  Genetics of neurodegeneration with brain iron accumulation.

Authors:  Allison Gregory; Susan J Hayflick
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

Review 2.  Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotection.

Authors:  Natalia B Nedelsky; Peter K Todd; J Paul Taylor
Journal:  Biochim Biophys Acta       Date:  2008-10-10

3.  Exome Sequencing Identifies a Novel Homozygous Missense ATP13A2 Mutation.

Authors:  Masoom M Abbas; Shyla T Govindappa; Una-Marie Sheerin; Kailash P Bhatia; Uday B Muthane
Journal:  Mov Disord Clin Pract       Date:  2016-04-26

4.  Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein.

Authors:  Jieqiong Tan; Tongmei Zhang; Li Jiang; Jingwei Chi; Dongshen Hu; Qian Pan; Danling Wang; Zhuohua Zhang
Journal:  J Biol Chem       Date:  2011-07-01       Impact factor: 5.157

Review 5.  α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease.

Authors:  Jason P Covy; Benoit I Giasson
Journal:  Neurotoxicology       Date:  2011-01-14       Impact factor: 4.294

6.  PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity.

Authors:  David Ramonet; Agata Podhajska; Klodjan Stafa; Sarah Sonnay; Alzbeta Trancikova; Elpida Tsika; Olga Pletnikova; Juan C Troncoso; Liliane Glauser; Darren J Moore
Journal:  Hum Mol Genet       Date:  2011-12-20       Impact factor: 6.150

7.  Mutant Atp13a2 proteins involved in parkinsonism are degraded by ER-associated degradation and sensitize cells to ER-stress induced cell death.

Authors:  Janet Ugolino; Shengyun Fang; Christian Kubisch; Mervyn J Monteiro
Journal:  Hum Mol Genet       Date:  2011-06-10       Impact factor: 6.150

8.  Characterization of cellular protective effects of ATP13A2/PARK9 expression and alterations resulting from pathogenic mutants.

Authors:  Jason P Covy; Elisa A Waxman; Benoit I Giasson
Journal:  J Neurosci Res       Date:  2012-07-30       Impact factor: 4.164

9.  ATP13A2 variability in Parkinson disease.

Authors:  Carles Vilariño-Güell; Alexandra I Soto; Sarah J Lincoln; Samia Ben Yahmed; Mounir Kefi; Michael G Heckman; Mary M Hulihan; Hua Chai; Nancy N Diehl; Rim Amouri; Alex Rajput; Deborah C Mash; Dennis W Dickson; Lefkos T Middleton; Rachel A Gibson; Faycal Hentati; Matthew J Farrer
Journal:  Hum Mutat       Date:  2009-03       Impact factor: 4.878

10.  Genetic analysis of the ATP1B4 gene in Chinese Han patients with Parkinson's disease.

Authors:  Kai Gao; Zhi Song; Hui Liang; Wen Zheng; Xiong Deng; Yi Yuan; Yongxiang Zhao; Hao Deng
Journal:  Mol Biol Rep       Date:  2014-01-14       Impact factor: 2.316
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.